Skip to content

Gabapentin's Effects on Insomnia in Patients With Recent Concussion

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01421264
Enrollment
21
Registered
2011-08-22
Start date
2011-08-31
Completion date
2013-06-30
Last updated
2023-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

concussion, gabapentin, neurontin, insomnia

Brief summary

In this open-label, pilot study the investigators will be assessing gabapentin's effects on insomnia and other concussion-related symptoms in patients with a recent concussion experiencing insomnia.

Interventions

DRUGGabapentin

300mg capsules by mouth

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Head trauma causing concussion with either no loss of consciousness (LOC) or LOC \< 30 minutes within previous 2 weeks. 2. ISS score at Baseline of \> 14. 3. PCSS score at Baseline \> 5. 4. If brain imaging has been checked, there was no intracerebral hemorrhage noted. 5. Glasgow Coma Scale score of 15 at Baseline. 6. Age of at least 14 years old. 7. Has not taken gabapentin or pregabalin any time since concussion and has no history of intolerance to gabapentin or pregabalin. 8. Has not taken any sleeping pills for previous 2 nights and agrees not to take any for the next 2 weeks.

Design outcomes

Primary

MeasureTime frame
Change in Insomnia Severity Index from Baseline to 1 week1 week

Secondary

MeasureTime frame
Change in Post Concussion Symptom Scale score from Baseline to 1 week1 week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026